Nutrients · 2019 · 31 citations · 31 references
MedicineCancer BiologyOncologyCancer PharmacologyMetastasisMolecular OncologyMalignant NeoplasmsMetastatic Breast CancerMetastatic Disease TreatmentTumor BiologyAnticancer ActivityBreast Cancer ProgressionCell Migration AnalysisCell Migration DynamicsCell Viability AssaysLamellipodia FormationMyc OverexpressionTherapeutic Plant Efficacy
Breast cancer (BC) is the second leading cause of cancer death among women worldwide. The main cause of BC morbidity and mortality is the invasiveness capacity of cancer cells that may lead to metastasis. Here, we aimed to investigate the therapeutic efficacy of Ganoderma lucidum extract (GLE)—a medicinal mushroom with anticancer properties—on BC motility via the Rac/Lamellipodin pathway. GLE treatment effects were tested on MDA-MB-231 breast cancer cells. The effects were tested on cell viability, migration and invasion. Pulldowns, immunoblotting, and immunofluorescence were used to measure Rac activity and the expression of proteins involved in cell migration and in lamellipodia formation, respectively. As a result, GLE suppressed BC cell viability, migration, and invasion capacity. GLE impaired Rac activity, as well as downregulated Lamellipodin, ENA/VASP, p-FAK (Tyr925), Cdc42, and c-Myc expression. Lamellipodia formation was significantly reduced by GLE. In conclusion, we demonstrate that GLE reduces Rac activity and downregulates signaling molecules involved in lamellipodia formation. These novel findings serve as basis for further studies to elucidate the potential of GLE as a therapeutic agent regulating the Rac/Lamellipodin pathway in BC metastasis.
31
Breast cancer statistics, 2017, racial disparity in mortality by state
Carol DeSantis, Jiemin Ma, Ann Goding Sauer et al. · CA A Cancer Journal for Clinicians · 2017 · 1.9K citations · Full text